- Washington DClearn more
- Registerfor event
- Logisticsvenue & travel
- Exhibitorslearn more
Monmouth, NJ Course
September 13, 2014
Washington DC Conference & Course
October 9-12, 2014
Network with Lyme Experts
Ask A Lyme Disease Question
Discount for ILADS Conferences
Lyme Training Materials
Join LymeWall - Tell Your Story
Create Fundraising Campaign
Become a Social Ambassador
Honor A Loved One
Learn, share and collaborate with experts in Lyme and associated diseases on ILADS members only site.
Gottfried Kellerman, PhD
Saturday, October 11th, 2014
1:30 PM - 5:00 PM: Breakout E - Laboratory Advances - Moderator: Raphael B. Stricker, MD
Laboratory Assessment of Lyme Disease (4:00 PM - 4:30 PM)
Speaker Bio: Gottfried Kellermann, Ph.D. is considered an authority in the assessment of clinical conditions for which the root cause is a neuro-immune imbalance. He received his Ph.D. from the University of Mainz (Germany) and has held key positions in oncology, biochemistry and research & development at universities and in private industry.
With a Ph.D. in Human Genetics and Biochemistry, Dr. Kellermann saw the value in tests on the market to evaluate individual nervous system biomarkers, but recognized the importance of gaining a more comprehensive picture. He believed that improvements in medical care would come when the interconnectedness of the neurological, immune, and endocrine systems was recognized and applied to a care plan designed to treat the body as a whole.
To make this kind of testing available to the practitioners across the US, Dr. Kellermann opened Pharmasan Labs, Inc. in 1996. Today, this CLIA-certified lab offers a wide variety of laboratory tests to evaluate each major system in the body including assessments for neurotransmitters and related analytes in saliva and urine and other assessments in the fields of virology, immunology, and endocrinology.
Dr. Kellermann is currently the president and CEO of NeuroScience, Inc., which he founded in 2000. NeuroScience offers a line of uniquely formulated products designed to address imbalances revealed by laboratory testing. NeuroScience has partnered with Pharmasan Labs to offer novel testing that identifies imbalances in neuro-immune markers for addressing core health issues as well as to offer novel testing such as iSpot Lyme.
The partnership of these two companies led Dr. Kellermann to pioneering the concept termed the Assess and Address approach, which allows practitioners to provide personalized patient care through novel laboratory assessments and treatment strategies. Current research endeavors include the incorporation of functional genetics and further applications for iSpot technologies.
ILADS is a nonprofit, international, multi-disciplinary medical society, dedicated to the diagnosis and appropriate treatment of Lyme and its associated diseases. ILADS promotes understanding of Lyme through research and education and strongly supports physicians and other health care professionals dedicated to advancing the standard of care for Lyme and its associated diseases. Learn more about us ?
Click Above to Share ILADS.org
PO Box 341461